Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(25%)

Phase Distribution

Ph phase_2

25%

Ph phase_1

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

2(66.7%)

Phase 2Efficacy & side effects

1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(1)

Other(1)

Detailed Status

Completed2

unknown1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 2

Trials by Phase

Phase 12 (66.7%)

Phase 21 (33.3%)

Trials by Status

unknown125%

completed250%

terminated125%

Recent Activity

0 active trials

Showing 4 of 4

unknown

Prospective Registry for Patients With Chest Pain in Emergency Department

NCT05058300

completedphase_2

Study to Assess the Effect of the NEXThaler® Device (DPI - Dry Powder Inhaler) on the Central and Peripheral Airway Dimensions in Asthmatic Patients

NCT01650441

terminatedphase_1

Computed Tomography (CT) in Head and Neck Patients

NCT00188656

completedphase_1

Dose Reduction in Thoracic CT

NCT00188461

Clinical Trials (4)

Showing 4 of 4 trials

NCT05058300

Prospective Registry for Patients With Chest Pain in Emergency Department

Unknown

NCT01650441Phase 2

Study to Assess the Effect of the NEXThaler® Device (DPI - Dry Powder Inhaler) on the Central and Peripheral Airway Dimensions in Asthmatic Patients

Completed

NCT00188656Phase 1

Computed Tomography (CT) in Head and Neck Patients

Terminated

NCT00188461Phase 1

Dose Reduction in Thoracic CT

Completed

All 4 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 4